Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancer

The current standard treatment for ovarian cancer is aggressive surgery followed by platinum-based combination chemotherapy. Recurrence and chemotherapeutic drug resistance are the two main factors that account for the high mortality of most ovarian cancers. Liposomal doxorubicin is primarily used f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuqin, Cao, Jian, Zhang, Wei, Zhang, Fan, Ni, Guantai, Luo, Qian, Wang, Man, Tao, Xiang, Xia, Hongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105059/
https://www.ncbi.nlm.nih.gov/pubmed/27833130
http://dx.doi.org/10.1038/srep36873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105059/
https://www.ncbi.nlm.nih.gov/pubmed/27833130
http://dx.doi.org/10.1038/srep36873

Ejemplares similares